Endometrial hyperplasia versus carcinoma: does phosphatase and tensin homolog immunohistochemical expression differentiate between them - Egyptian Knowledge Bank - troweb

370275

Endometrial hyperplasia versus carcinoma: does phosphatase and tensin homolog immunohistochemical expression differentiate between them

Article

Last updated: 21 Dec 2024

Overview Similar Items

Article

Value of H-TERT and CD10 in differentiating endometrial carcinoma from atypical endometrial hyperplasia: an immunohistochemical study

Article

A Comprehensive Clinicopathological Analysis of Carcinoma of Endometrium: Histotype- Immunophenotype Correlation

Article

Predictors of progestin therapy response in endometrial hyperplasia: An immunohistochemical study

Article

INTERNATIONAL ENDOMETRIAL TUMOR ANALYSIS AND ITS RELATION TO ENDOMETRIAL PATHOLOGY

Article

Her-2 Neu Expression in Endometrial Carcinoma

Article

P53 EXPRESSION AS A RISK FACTOR IN TYPE 1 ENDOMETRIAL CANCER

Article

Stratification of Endometrial Carcinoma Patients Using Immunohistochemistry for Better Surgical Planning and Prognosis

Article

Correlation of Endometrial Thickness and Histopathological in Women with Post-Menopausal Bleeding

Article

Expression of Her-2/neu in endometrial carcinoma and its relation with clinicopathological variables

Article

EpCAM Expression in Epithelial Ovarian Cancer: Immunohistochemical and Histopathological Study